The prognosis of bone malignant tumours varies depending on the tumour type. Currently, the 5-year survival rate for osteosarcoma after comprehensive treatment can reach 60% to 70%, and the 5-year survival rate for Ewing’s sarcoma exceeds 50%. Chondrosarcoma has a different prognosis depending on the subtype, and myeloma has a relatively poor prognosis.